MedPath

CO-ADAPT: Adaptive Environments and Conversational Agent Based Approaches for Healthy Ageing and Work Ability

Not Applicable
Completed
Conditions
Psychologic Adaptation
Work Related Stress
Interventions
Behavioral: SMT
Device: App CA
Registration Number
NCT04809090
Lead Sponsor
Tommaso Ciulli
Brief Summary

The purpose of this study is to identify effective methodologies to help people improve their ability to adapt to psychological stress.

Detailed Description

The subjects involved will follow a Stress Management Training (SMT) to learn some techniques to manage stress in the workplace and to increase the effectiveness of the intervention will use an APP and a Conversational Agent (CA) an Artificial Intelligence (AI).

The purpose of the smartphone Application (APP) and CA will be to help people identify their thoughts, help them understand their emotions and the events that generated them.

The data collected and analyzed will be integrated into artificial intelligence to improve understanding of what people are writing.

Based on these analyses, it will be possible to identify the many different variables that interact in cases where a subject shows signs of stress related to adapting to change in the work environment and possible resilience factors that contribute to decreasing the state of stress.

Tests will be administered at the beginning, at the end of the meetings, and 3 months after the end of the sessions. Subjects will be divided into various groups to understand whether APP and CA have a significant impact in increasing psychological well-being and stress coping strategies.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • whitecollar
  • Normal or moderate levels of anxiety and stress
  • A sufficient level of education to understand study procedures and be able to communicate with site personnel
  • at least 40 to 70 years old
Exclusion Criteria
  • High levels of depression combined with other psychological risk indices (such as suicidal thoughts)
  • Current use of narcotics or other substances

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
SMT+CASMTThis group will receive a standard 8 SMT (Stress Management Training) psychological interviews and subjects will use an APP together a CA (Conversational Agent) an Artificial Intelligence.
SMT+CAApp CAThis group will receive a standard 8 SMT (Stress Management Training) psychological interviews and subjects will use an APP together a CA (Conversational Agent) an Artificial Intelligence.
Only CAApp CAThis group will receive only an APP together a CA (Conversational Agent) an Artificial Intelligence.
SMT GroupSMTThis group will receive a standard 8 SMT (Stress Management Training) psychological interviews
Primary Outcome Measures
NameTimeMethod
An improvement of the scales contained in the OSI questionnaireUp to day 60

The Occupational Stress Indicator (OSI) test is a validated tool to detect sources of stress, coping styles, and the effects of stress on the job.

An average improvement in Perceived Stress Scale (PSS) test scoresUp to day 60

The Perceived Stress Scale (PSS) test is a validated test for detecting general stress levels.

Secondary Outcome Measures
NameTimeMethod
An improvement in levels of general psychological well-being Symptom Check List-90-Revised (SCL-90-R)Up to day 60

The Symptom Check List-90-Revised (SCL-90-R) test is a validated test for the detection of some psychological scales such as anxiety, depression and the level of general psychological well-being.

An improvement in levels of GAD-7 test scoresUp to day 60

The GAD-7 test is a validated test for the detection of generalized anxiety disorder. GAD-7 total score for the seven items ranges from 0 to 21. Higher scores mean worse outcome.

An improvement in levels of PHQ-8 test scoresUp to day 60

The PHQ-8 test is a validated test for the detection of depression. The PHQ-8 is scored just like the PHQ-9 and its total score ranges from 0 to 24. Higher scores mean worse outcome.

Trial Locations

Locations (1)

Idego srl

🇮🇹

Rome, Italy

© Copyright 2025. All Rights Reserved by MedPath